Search
Home
Catalog
2
Help
Help
Contact Us
FAQ
Jump to content
AMCP Learn
Search
Open menu
Cart
AMCP Learn login
Register
Bookmark/Search this post
Facebook
Twitter
LinkedIn
Forward
Home
Catalog
Help
Contact Us
FAQ
You are here
Home
Search
Takeda-FMCP Module 2: Pharmacy Benefit Management Tools
Gene Therapy in Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Retinopathy (DR)
APFM Section 1 Module 1: Formulary Overview
APFM Section 1 Module 3: PBM
APFM Section 1 Module 4: Regulatory and Legal Considerations
APFM Section 2 Module 2: Clinical Evaluation
APFM Section 2 Module 3: Value Assessment
APFM Section 2 Module 4: Utilization Management and Coverage Decision
APFM Section 2 Module 5: Special Considerations and Hot Topics
APFM Section 3 Module 1: Overview of Formulary Operations
APFM Section 3 Module 2: Formulary Communication and Education
APFM Section 3 Module 3: Utilization Management Administration
APFM Section 4 Module 1: Classification Systems
APFM Section 4 Module 2: Formulary Maintenance Considerations
APFM Section 4 Module 4: Best Practices for Utilizing Formulary Resources
Market Insights Best Practice on Food Allergies Part 1
Redefining Treatment for Hypoparathyroidism in Adults: When Patients Are Inadequately Controlled on Conventional Therapy
Thirty Years of Targeted Immuno-Modulators Evolution: More of the Same or Formulary Necessity?
A Preventive Treatment Option for Adults with Migraine
A CGRP Receptor Antagonist for the Acute Treatment of Migraine: Focus on Early Treatment
APFM Section 2 Module 1: P&T Committee
APFM Section 1 Module 2: Utilization Management
AMCP Market Insights: Idiopathic Hypersomnia
APFM Section 4 Module 3: Strategies for Monitoring the Formulary
Non-alcoholic Steatohepatitis (NASH) Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Voice
Pages
« first
‹ previous
1
2
3
next ›
last »
Facebook
Twitter
LinkedIn
Forward